Investing.com - Ocular Therapeutix (NASDAQ:OCUL) Inc reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Ocular Therapeutix Inc announced earnings per share of $-0.31 on revenue of $11.97M. Analysts polled by Investing.com anticipated EPS of $-0.23 on revenue of $14.6M.
Ocular Therapeutix Inc shares are up 100% from the beginning of the year, still down 54.83% from its 52 week high of $7.86 set on November 9, 2021.
Ocular Therapeutix Inc follows other major Healthcare sector earnings this month
Ocular Therapeutix Inc's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar